Maravai LifeSciences Holdings Inc
MRVI
NGS
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
26.28
USD
-0.03
(-0.11%)
Optionable: Yes Market Cap: 3,382 M 90-day average vol: 1,276,716
Previous close: 26.31 Open: 26.21 Bid: 26.58 Ask: 26.58
52 week range
23.05 63.55
Last updated: Friday 5th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Metrics
Valuation
Price per Sales TTM ($) | 4.99 |
Price per Book TTM ($) | 8.79 |
PE Ratio (TTM) | 14.10 |
Book Value per Share ($) | 2.91 |
5 Year PE Range | NA , NA |
Returns
7 Day Return | 2.18% | |
1 Month Return | -10.37% | |
3 Month Return | -18.81% | |
1 Year Return | -49.42% | |
3 Year Return | -11.96% | |
5 Year Return | -11.96% | |
YTD Return | -37.28% |
Risk
Analyst Estimates
Financial Health
Technicals
RSI (14 Day) | 46.99 |
14 Day SMA ($) | 25.83 |
14 Day EMA ($) | 26.11 |
Money Flow Index | 60.96 |
Average True Range | 1.39 |
50 Day SMA ($) | 28.31 |
200 Day SMA ($) | 33.98 |
ADX | 23.40 |
MACD | -0.70 |
Growth
Free Cash Flow QoQ Growth | 203.89% |
Free Cash Flow YoY Growth | 0.00% |
Revenue YoY Growth | 0.00% |
EPS QoQ Growth | 21.43% |
Revenue QoQ Growth | 6.94% |
EPS YoY Growth | 0.00% |
Profitability
Chart
News
Maravai LifeSciences Holdings, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Yahoo Finance 2/26/2022
Maravai LifeSciences surges as Sartorius makes $11B bid (updated)
Seeking Alpha 2/25/2022
Can Maravai LifeSciences Holdings, Inc. (MRVI) Run Higher on Rising Earnings Estimates?
Yahoo Finance 2/25/2022
Can Maravai LifeSciences Holdings, Inc. (MRVI) Climb 56% to Reach the Level Wall Street Analysts Expect?
Yahoo Finance 2/24/2022
Maravai LifeSciences Holdings, Inc. (MRVI) Carl Hull on Q4 2021 Results - Earnings Call Transcript
Seeking Alpha 2/23/2022
Maravai LifeSciences Holdings, Inc. 2021 Q4 - Results - Earnings Call Presentation
Seeking Alpha 2/23/2022
Maravai LifeSciences Holdings, Inc. (MRVI) Q4 Earnings and Revenues Beat Estimates
Yahoo Finance 2/23/2022
Maravai LifeSciences Holdings GAAP EPS of $0.42 beats by $0.08, revenue of $228.44M beats by $20.35M
Seeking Alpha 2/23/2022
Maravai LifeSciences Reports Fourth Quarter and Full Year 2021 Financial Results and Updates 2022 Financial Guidance
Yahoo Finance 2/23/2022
Maravai LifeSciences Q4 2021 Earnings Preview
Seeking Alpha 2/22/2022
Monashee Investment Management LLC Buys Vanguard Total Stock Market ETF, Hyperfine Inc, Agree ...
Yahoo Finance 2/7/2022
How Did Hedge Funds’ Maravai LifeSciences Holdings, Inc. (MRVI) Bets Fare?
Yahoo Finance 2/7/2022
Ownership Capital B.V. Buys Veeva Systems Inc, DexCom Inc, CoStar Group Inc, Sells Boston ...
Yahoo Finance 2/1/2022
3 Biotech Stocks That Could Deliver 5X Gains by 2030
Yahoo Finance 1/30/2022
Maravai LifeSciences acquires MyChem for $240M
Seeking Alpha 1/28/2022
Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure Nucleotides
Yahoo Finance 1/28/2022
Is Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) A High Quality Stock To Own?
Yahoo Finance 1/28/2022
Maravai Faces Skeptical Investors As Pandemic Enters New Period
Seeking Alpha 1/27/2022
Maravai LifeSciences Announces Upcoming Investor Events
Yahoo Finance 1/25/2022
Maravai LifeSciences announces debt repricing
Seeking Alpha 1/20/2022
Maravai LifeSciences Announces Debt Repricing
Yahoo Finance 1/20/2022
Trend Analysis & Forecast
Read more on this trend analysis & forecast here - uptrenddowntrend.com
Trendlast: 25.245
Financials
MRVI Income Statement
Annual
| Invalid date | Dec-18 | Dec-19 | Dec-20 | Dec-21 | |
|---|---|---|---|---|---|
| Total revenues | 124 M | 143 M | 284 M | 799 M | |
| Cost of sales | 38 M | 43 M | 54 M | 116 M | |
| Gross operating profit | 63 M | 76 M | 204 M | 659 M | |
| Selling Gen & administrative expense | 42 M | 49 M | 94 M | 100 M | |
| Research & development expense | 4 M | 4 M | 9 M | 15 M | |
| Operating income | 17 M | 24 M | 101 M | 543 M | |
| floaterest income | 0 | 0 | 0 | 0 | |
| floaterest expense | 0 | 0 | 0 | 0 | |
| Other income net | -6 M | -204000 | 12 M | 18 M | |
| Pre-tax Income (EBT) | -16 M | -6 M | 82 M | 531 M | |
| Income taxes | 417000 | -652000 | 3 M | 62 M | |
| Net income from total operations | -17 M | -5 M | 79 M | 469 M | |
| Minority floaterest | 0 | 0 | 0 | 0 | |
| Total net income | -18 M | -8 M | 77 M | 182 M | |
| Preferred dividends | N/A | N/A | N/A | N/A | |
| Net income available for common | -17 M | -5 M | 79 M | 469 M | |
| Depreciation | 22 M | 24 M | 26 M | 25 M | |
| Amortization | 0 | 0 | 0 | 0 | |
| Operating income before depreciation (EBITDA) | 33 M | 48 M | 138 M | 586 M | |
| Total Income available for floaterest expense (EBIT) | 0 | 0 | 0 | 0 | |
| Basic EPS total | -0.07 | -0.05 | 7.43 | 1.59 | |
| Diluted EPS total | -0.07 | -0.05 | 2.36 | 1.56 |
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!